Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 17:9:5.
doi: 10.1186/s40035-019-0181-9. eCollection 2020.

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

Affiliations
Review

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

Niccolo Candelise et al. Transl Neurodegener. .

Abstract

Background: α-Synuclein is a small soluble protein, whose physiological function in the healthy brain is poorly understood. Intracellular inclusions of α-synuclein, referred to as Lewy bodies (LBs), are pathological hallmarks of α-synucleinopathies, such as Parkinson's disease (PD) or dementia with Lewy bodies (DLB).

Main body: Understanding of the molecular basis as well as the factors or conditions promoting α-synuclein misfolding and aggregation is an important step towards the comprehension of pathological mechanism of α-synucleinopathies and for the development of efficient therapeutic strategies. Based on the conversion and aggregation mechanism of α-synuclein, novel diagnostic tests, such as protein misfolding seeded conversion assays, e.g. the real-time quaking-induced conversion (RT-QuIC), had been developed. In diagnostics, α-synuclein RT-QuIC exhibits a specificity between 82 and 100% while the sensitivity varies between 70 and 100% among different laboratories. In addition, the α-synuclein RT-QuIC can be used to study the α-synuclein-seeding-characteristics of different α-synucleinopathies and to differentiate between DLB and PD.

Conclusion: The variable diagnostic accuracy of current α-synuclein RT-QuIC occurs due to different protocols, cohorts and material etc.. An impact of micro-environmental factors on the α-synuclein aggregation and conversion process and the occurrence and detection of differential misfolded α-synuclein types or strains might underpin the clinical heterogeneity of α-synucleinopathies.

Keywords: Protein misfolding; Protein strains; RT-QuIC; α-Synucleinopathies.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Diagram of the potential seeding-conversion mechanism of α-synuclein during the RT-QuIC. The seed (in red) triggers the aggregation of monomeric α-synuclein (substrate, in green). The conversion causes the conformational modification into misfolded oligomers (blue) that elongate into fibrils. After the detection of fibrils, a quaking event breaks the longer fibrils into shorter, reactive oligomers, which further seed the conversion of monomeric α-synuclein (modified from [92]). The classical shape of the kinetic curve is shown within the aggregation process
Figure 2
Figure 2
Proposed models for the aggregation pathway. a Established schematic view for the pathway of aggregation of natively unfolded proteins [40]. According to this model, from an unfolded protein (UN) is formed an intermediate (I), which further aggregates into protofibrils (P) and eventually into fibrils (F). b The extended model we propose takes into account the possibility that a population of strains are produced, together with off-pathway oligomers that do not show the ability to form α-synuclein fibrils. Intermediate forms marked as I1 to In, each of them may produce a different protofibrillar form, marked as P1-n to Pn-n (the protofibril P1 derived from the intermediate I1 until the protofibril Pn derived from the intermediate In). It is noteworthy to state that the process may be in equilibrium between the aggregation of the intermediates and the rupture of protofibrillar forms. Further aggregation will cause the collapse into a limited number of fibrillar structures

References

    1. Halliday GM, Holton JL, Revesz T, Dickson DW. Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol. 2011;122:187–204. doi: 10.1007/s00401-011-0852-9. - DOI - PubMed
    1. Schönfelder J, Alonso-Caballero A, De Sancho D, Perez-Jimenez R. The life of proteins under mechanical force. Chem Soc Rev. 2018;47(10):3558–3573. doi: 10.1039/C7CS00820A. - DOI - PubMed
    1. Balchin D, Hayer-Hartl M, Hartl FU. In vivo aspects of protein folding and quality control. Science. 2016;353(6294):acc4354. doi: 10.1126/science.aac4354. - DOI - PubMed
    1. Eisenberg D, Jucker M. The amyloid state of proteins in human diseases. Cell. 2012;148(6):1188–1203. doi: 10.1016/j.cell.2012.02.022. - DOI - PMC - PubMed
    1. Oldfield Christopher J., Dunker A. Keith. Intrinsically Disordered Proteins and Intrinsically Disordered Protein Regions. Annual Review of Biochemistry. 2014;83(1):553–584. doi: 10.1146/annurev-biochem-072711-164947. - DOI - PubMed

Publication types